Đang chuẩn bị liên kết để tải về tài liệu:
Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Another limitation of the literature is that minorities have been dramatically under- represented in psycho-oncology research (Anderson, 1992). Further, although the research demonstrates the importance of the spousal relationship during the cancer experience, there is a lack of controlled research concerning couples or family interventions. Finally, a crucial question that remains unanswered is determining what these findings mean in terms of clinical intervention and care. It is yet unclear if precise psychosocial factors can be manipulated to effect quality of life and disease outcome. Despite these limitations, the current literature holds important clinical implications for the field that will be dis- cussed later in the article

TÀI LIỆU LIÊN QUAN

Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: A prospective study

Research on chronic HBV infection and risk factors in patients with liver cancer in the hospital of Hue college of medicine and pharmacy

Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy

Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: A long-term cohort study

Sách: Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry

ChARM: Discovery of combinatorial chromatin modification patterns in hepatitis B virus X-transformed mouse liver cancer using association rule mining

Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

HBV-related hepatocarcinogenesis: The role of signalling pathways and innovative ex vivo research models

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: Basing on competing risk model
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.